Skip to main content
. Author manuscript; available in PMC: 2010 Aug 10.
Published in final edited form as: J Med Chem. 2007 Aug 16;50(18):4493–4500. doi: 10.1021/jm070569b

Figure 3.

Figure 3

Cell cycle distribution analyses of HL-60 and HL-60/MX2 cells as a function of exposure to doxorubicin or doxazolidine. HL-60 and HL-60/MX2 cells were treated with 100 nM doxorubicin (DOX), doxazolidine (DOXAZ) or vehicle for 24 h and analyzed for cell cycle distribution. Cells lines are defined in the legend to Figure 2.